GBBWRPM
IDXX icon

Genovese Burford & Brothers Wealth & Retirement Plan Management’s Idexx Laboratories IDXX Stock Holding History

Genovese Burford & Brothers Wealth & Retirement Plan Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-200
Closed -$44K – 209
2018
Q2 		$44K Hold
200
– – 0.02% 187
2018
Q1 		$38K Hold
200
– – 0.01% 194
2017
Q4 		$38K Buy
+200
New +$31.5K 0.1% 105

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Genovese Burford & Brothers Wealth & Retirement Plan Management's IDXX Position: Q3 2018 in Review

Genovese Burford & Brothers Wealth & Retirement Plan Management sold out of Idexx Laboratories (IDXX) in Q3 2018, closing a stake of 200 shares — an estimated $44K sold.

Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in IDXX in Q4 2017 and held it in 3 quarters. The position peaked at $44K in Q2 2018. 698 funds tracked by Wall St. Rank hold IDXX as of Q3 2018.

  • Genovese Burford & Brothers Wealth & Retirement Plan Management reported no remaining Idexx Laboratories position as of Q3 2018 after selling out during the quarter.
  • Genovese Burford & Brothers Wealth & Retirement Plan Management sold 200 Idexx Laboratories shares in Q3 2018, an estimated $44K.
  • Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in Idexx Laboratories in Q4 2017 and held it in 3 quarters.
  • Genovese Burford & Brothers Wealth & Retirement Plan Management's Idexx Laboratories position peaked at $44K in Q2 2018.
  • 698 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2018.

Based on Genovese Burford & Brothers Wealth & Retirement Plan Management's 13F filing for Q3 2018, filed 13 Nov 2018.